CDK4 and breast carcinoma: We found using datasets associated with resistance to CDK4/6 inhibitors in the Gene Expression Omnibus (GEO) that more CPVL was expressed in resistant, than sensitive breast cancer cells, implying a potential role in regulating drug resistance.